Viewing StudyNCT00895882



Ignite Creation Date: 2024-05-05 @ 9:30 PM
Last Modification Date: 2024-10-26 @ 10:05 AM
Study NCT ID: NCT00895882
Status: WITHDRAWN
Last Update Posted: 2015-10-22
First Post: 2009-05-06

Brief Title: Study to Evaluate Different Regimens of Vaniprevir MK7009 for the Treatment of Chronic Genotype 1 Hepatitis C Virus Infection in Treatment-naive Patients MK-7009-019WITHDRAWN
Sponsor:
Organization: Merck Sharp Dohme LLC

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 0
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: